Publications by authors named "Emel Bayar"

Claim this Profile
P
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Jean-Pierre J Issa, Guillermo Garcia-Manero, Francis J Giles, Rajan Mannari, Deborah Thomas, Emel Bayar

Blood· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.
John Lyons, Emel Bayar, Gil Fine, Michael McCullar, Randee Rolens

Curr Opin Investig Drugs· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis